<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report the case of an elderly woman with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>, risk factors for vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, and atrium-ventricular blockade, who presented with severe <z:hpo ids='HP_0000713'>agitation</z:hpo> and <z:hpo ids='HP_0000709'>psychosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>She was treated with <z:chebi fb="0" ids="31236">aripiprazole</z:chebi> and assessed with the Neuropsychiatric Inventory (NPI) over the course of 14 weeks </plain></SENT>
<SENT sid="2" pm="."><plain>NPI scores showed a marked decrease in <z:hpo ids='HP_0000709'>psychosis</z:hpo> and <z:hpo ids='HP_0000713'>agitation</z:hpo> at week 4, and complete recovery at week 14, except for <z:hpo ids='HP_0000716'>depression</z:hpo> </plain></SENT>
</text></document>